norgestrel has been researched along with Cell Transformation, Neoplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayatpour, M; Pater, A; Pater, MM | 1 |
| Black, WC; Bredfeldt, JE; Gyorffy, EJ | 1 |
| Dallenbach-Hellweg, G; Fenzel, J | 1 |
3 other study(ies) available for norgestrel and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives.
Topics: Administration, Oral; Animals; Cell Transformation, Neoplastic; Cells, Cultured; Contraceptives, Oral; DNA, Viral; Drug Combinations; Female; Kidney; Norgestrel; Papillomaviridae; Progesterone; Progestins; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Rats; Rats, Inbred F344; Uterine Cervical Neoplasms | 1990 |
Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use.
Topics: Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Liver Neoplasms; Middle Aged; Norgestrel; Precancerous Conditions | 1989 |
[Dependence of morphologic changes in portio, cervix and endometrium on dosage or potency of synthetic gestagens].
Topics: Cell Transformation, Neoplastic; Cervix Uteri; Desogestrel; Dose-Response Relationship, Drug; Endometrium; Female; Humans; Lynestrenol; Norgestrel; Norpregnenes; Progesterone Congeners; Risk; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Uterine Neoplasms; Vagina; Vaginal Neoplasms | 1985 |